Zolsketil pegylated liposomal Evropská unie - čeština - EMA (European Medicines Agency)

zolsketil pegylated liposomal

accord healthcare s.l.u. - doxorubicin hydrochloride, liposomal - ovarian neoplasms; sarcoma, kaposi; multiple myeloma - doxorubicin - zolsketil pegylated liposomal is a medicine used to treat the following types of cancer in adults:• breast cancer that has spread to other parts of the body in patients at risk of heart problems. zolsketil pegylated liposomal is used on its own for this disease;• advanced ovarian cancer in women whose previous treatment including a platinum-based cancer medicine has stopped working;• multiple myeloma (a cancer of the white blood cells in the bone marrow), in patients with progressive disease who have received at least one other treatment in the past and have already had, or are unsuitable for, a bone marrow transplantation. zolsketil pegylated liposomal is used in combination with bortezomib (another cancer medicine);• kaposi’s sarcoma in patients with aids who have a very damaged immune system. kaposi’s sarcoma is a cancer that causes abnormal tissue to grow under the skin, on moist body surfaces or on internal organs. zolsketil pegylated liposomal contains the active substance doxorubicin and is a ‘hybrid medicine’. this means that it is similar to a ‘reference medicine’ containing the same active substance called adriamycin. however, in zolsketil pegylated liposomal the active substance is enclosed in tiny fatty spheres called liposomes, whereas this is not the case for adriamycin.

AMLODIPIN ACCORD 10MG Tableta Česká republika - čeština - SUKL (Státní ústav pro kontrolu léčiv)

amlodipin accord 10mg tableta

accord healthcare polska sp. z o.o., varšava array - 12990 amlodipin-besilÁt - tableta - 10mg - amlodipin

AMLODIPIN ACCORD 5MG Tableta Česká republika - čeština - SUKL (Státní ústav pro kontrolu léčiv)

amlodipin accord 5mg tableta

accord healthcare polska sp. z o.o., varšava array - 12990 amlodipin-besilÁt - tableta - 5mg - amlodipin

AURASTH 50MCG/100MCG Dávkovaný prášek k inhalaci Česká republika - čeština - SUKL (Státní ústav pro kontrolu léčiv)

aurasth 50mcg/100mcg dávkovaný prášek k inhalaci

neutec inhaler ireland limited, dublin irsko - 14181 salmeterol-xinafoÁt; 12768 flutikason-propionÁt - dávkovaný prášek k inhalaci - 50mcg/100mcg - salmeterol a flutikason

AURASTH 50MCG/250MCG Dávkovaný prášek k inhalaci Česká republika - čeština - SUKL (Státní ústav pro kontrolu léčiv)

aurasth 50mcg/250mcg dávkovaný prášek k inhalaci

neutec inhaler ireland limited, dublin irsko - 14181 salmeterol-xinafoÁt; 12768 flutikason-propionÁt - dávkovaný prášek k inhalaci - 50mcg/250mcg - salmeterol a flutikason

BETAHISTIN AUROVITAS 16MG Tableta Česká republika - čeština - SUKL (Státní ústav pro kontrolu léčiv)

betahistin aurovitas 16mg tableta

aurovitas, spol. s r.o., praha ČeskÁ republika - 3444 betahistin-dihydrochlorid - tableta - 16mg - betahistin

BETAHISTIN AUROVITAS 8MG Tableta Česká republika - čeština - SUKL (Státní ústav pro kontrolu léčiv)

betahistin aurovitas 8mg tableta

aurovitas, spol. s r.o., praha ČeskÁ republika - 3444 betahistin-dihydrochlorid - tableta - 8mg - betahistin

BUPIVACAINE ACCORD 2,5MG/ML Injekční roztok Česká republika - čeština - SUKL (Státní ústav pro kontrolu léčiv)

bupivacaine accord 2,5mg/ml injekční roztok

accord healthcare polska sp. z o.o., varšava polsko - 12336 monohydrÁt bupivakain-hydrochloridu - injekční roztok - 2,5mg/ml - bupivakain

BUPIVACAINE ACCORD 5MG/ML Injekční roztok Česká republika - čeština - SUKL (Státní ústav pro kontrolu léčiv)

bupivacaine accord 5mg/ml injekční roztok

accord healthcare polska sp. z o.o., varšava polsko - 12336 monohydrÁt bupivakain-hydrochloridu - injekční roztok - 5mg/ml - bupivakain

ENTECAVIR AUROVITAS 0,5MG Potahovaná tableta Česká republika - čeština - SUKL (Státní ústav pro kontrolu léčiv)

entecavir aurovitas 0,5mg potahovaná tableta

aurovitas, spol. s r.o., praha array - 18161 monohydrÁt entekaviru - potahovaná tableta - 0,5mg - entekavir